Sell Your Silvercorp Stock and Options — and Book 43.94% Gains in Novo Nordisk in Just 11 Trading Days!

Nicholas Vardy

Nicholas Vardy has a unique background that has proven his knack for making money in different markets around the world.

The good news is that SVM is up a solid 17.64% since my recommendation on Nov. 22 — and is actually up 45.5% since it bottomed on Jan. 24.

The less good news is that the options I recommended — the March $12.50 calls — are now just about back up to even — actually down 3.13% based on yesterday’s close. That was because SVM corrected substantially in January, and has been digging itself out of a deep hole.

With the options expiring in a little more than two weeks, I am recommending that you sell your options today. You roughly will break even on this trade, but with so little time remaining on the options, I don’t want you to risk any more on this position.

I am also recommending that with silver so overbought, and uncertainty in global markets high, you sell your SVM stock as well to lock in your 17.64% gains. We will be returning to the silver theme in future recommendations.

In addition, I am recommending that you sell half of your June 2011 $120 call options in Novo Nordisk (NVO) to lock in a 43.94% gain. With global stock markets increasingly unsteady, that’s not a bad return for a position you got into on Feb. 14!

With your remaining options expiring in June, and the fundamentals of Novo Nordisk still in place, hold on to both the stock and your remaining options for potentially bigger gains, still.


Like This Article?
Now Get Our FREE Special Report:
Alternative Investing: Investing in Timber

Stock Investor editor Paul Dykewicz reveals why investing in timber may be one of the best long-term portfolio strategies you'll find today.

Get Access to the Report, 100% FREE

previous article

With global markets turning nervous about the situation in Libya, last week was a roller coaster for your Global Bull Market Alert portfolio. That said, several of your Global Bull Market Alert positions, including your last stock recommendation, Denmark's Novo Nordisk (NVO), as well as Alliance Resource Partners LP (ARLP), hit 52-week highs during the week. With markets bouncing sharply on Friday, 10 of your 12 current recommendations are showing a profit -- five of


Dr. Mark Skousen

Named one of the "Top 20 Living Economists," Dr. Skousen is a professional economist, investment expert, university professor, and author of more than 25 books.

Product Details


Bryan Perry

A former Wall Street financial advisor with three decades' experience, Bryan Perry focuses his efforts on high-yield income investing and quick-hitting options plays.

Product Details


Jim Woods

Jim Woods has over 20 years of experience in the markets from working as a stockbroker,
financial journalist, and money manager. As well as a book author and regular contributor to
numerous investment websites, Jim is the editor of:

Product Details


Bob Carlson

Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.

Product Details


Hilary Kramer

Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. Since 2010, Hilary's financial publications have provided stock analysis and investment advice to her subscribers:

Product Details


Used by financial advisors and individual investors all over the world, is the premier provider and one-stop shop for dividend information and research.

Product Details

Popular tools include our proprietary Dividend Calendar, Dividend Calculator, Dividend Score Card, and many more.